MAP1LC3A and Parkinson disease: Hence, we also evaluated the expression of LC3A, an autophagic marker, and a significant decrease in LC3 expression was observed in samples obtained from PD patients and neurotoxin-treated SNpc samples (Fig. 1b, c).